Primary Care Clinics in Michigantown, IN Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Proactive Mso, Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 725 N State Road 29, Michigantown, IN 46057 Phone: 864-501-0751 |
News Archive
Merck announces approval of NOXAFIL delayed-release tablets by FDA
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL® (posaconazole) 100 mg delayed-release tablets.
Luminex donates new MAGPIX system to Papua New Guinea Institute of Medical Research
Luminex Corporation, the worldwide leader in multiplexed solutions, today announced it has donated the first commercial unit of its newly launched MAGPIX® instrument to Professor Peter Siba and his scientific team at the Papua New Guinea Institute of Medical Research. The instrument will be used onsite in Papua New Guinea to progress malaria research led by Dr. Peter Zimmerman, Professor of International Health, Genetics and Biology at the Center for Global Health and Diseases at Case Western Reserve University.
Toilet training method not related to urinary accidents in children
Parents: stop worrying about which toilet training method to use - where urinary accidents in children are concerned, it doesn't matter. This clearly-stated message, published today in Clinical Pediatrics by physician researchers from the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School and The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital, emphasizes that the method of training chosen by parents is not the cause of urinary accidents in children.
Mint flavored e-cigarettes found to be popular among U.S. teens
A new USC study shows that mint was the most popular flavor of e-cigarettes used by U.S. teens in 2019, a finding that could impact proposed federal regulations intended to rein in soaring e-cig use among youth.
Amgen's Prolia receives FDA approval for new indications to treat cancer patients
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
› Verified 9 days ago